1. Veterans Affairs Central Cancer Registry (VACCR) [intranet database]. Washington, DC: US Department of Veterans Affairs; 1995.
2. U.S. Department of Veterans Affairs. National Center for Veterans Analysis and Statistics. Profile of Veterans: 2009. Data from the American Community Survey. U.S. Department of Veterans Affairs Website. http://www.va.gov/vetdata/docs/SpecialReports/Profile_of_Veterans_2009_FINAL.pdf. Accessed July 23, 2014.
3. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Website. http://www.seer.cancer.gov. Accessed July 23, 2014.
4. Uchio EM, Aslan M, Wells CK, Calderone J, Concato J. Impact of biochemical recurrence in prostate cancer among US veterans. Arch Intern Med. 2010;170(15):1390-1395.
5. U.S. Department of Veterans Affairs. VHA DIRECTIVE 2003-034. Department of Veterans Affairs, Veterans Health Administration Website. http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=261. Accessed July 23, 2014.
6. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113(9):2464-2470.
7. Harrop JP, Dean JA, Paskett ED. Cancer survivorship research: A review of the literature and summary of current NCI-designated cancer center projects. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2042-2047.
8. Centers for Disease Control and Prevention. Cancer survivors—United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60(9):269-272.
9. Ganz PA. Survivorship: Adult cancer survivors. Prim Care. 2009;36(4):721-741.
10. Hewitt M, Greenfield S, Stovall E, eds. From Cancer Patient to Cancer Survivor: Lost in Translation . Institute of Medicine and National Research Council of the National Academies. Washington, DC: The National Academies Press; 2005.
11. Moye J, Schuster JL, Latini DM, Naik AD. The future of cancer survivorship care for veterans. Fed Pract. 2010;27(3):36-43.
12. Darwish-Yassine M, Berenji M, Wing D, et al. Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study. J Cancer Surviv. 2014;8(1):121-130.
13. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250-1261.
14. Kelley M. VA Proposes Team-Based Model for Prostate Cancer Care. U.S. Medicine Website. http://www.usmedicine.com/agencies/department-of-veterans-affairs/va-proposes-team-based-model-for-prostate-cancer-care. Published May 2013. Accessed April 28, 2014.
15. Bill-Axelson A, Holmberg L, Ruutu M, et al; Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352(19):1977-1984.
16. Skolarus TA, Miller DC, Zhang Y, Hollingsworth JM, Hollenbeck BK. The delivery of prostate cancer care in the United States: Implications for delivery system reform. J Urol. 2010;184(6):2279-2284.
17. NCCN Clinical Practice Guidelines in Oncology Prostate Cancer, Version 2.2014. NCCN Website. http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed April 1, 2014.
18. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 2002;360(9327):103-106.
19. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126-131.
20. Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA . 2011;306(11):1205-1214.
21. Dandapani SV, Sanda MG. Measuring health-related quality of life consequences from primary treatment for early-state prostate cancer. Semin Radiat Oncol. 2008;18(1):67-72.
22. Johansson E, Steineck G, Holmberg L, et al; SPCG-4 Investigators. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Proste Cancer Group-4 randomised trial. Lancet Oncol. 2011;12(9):891-899.
23. Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G; Scandinavian Prostate Cancer Group Study No 4. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol. 2009;55(2):422-430.
24. Steineck G, Helgesen F, Adofsson J, et al; Scandanavian Prostatic Cancer Group Study Number 4. Quality of life after radial prostatectomy or watchful waiting. N Engl J Med. 2002;347(11):790-796.
25. Penson DF, Litwin MS. Quality of life after treatment for prostate cancer. Curr Urol Rep. 2003;4(3):185-195.
26. Ferrer M, Suárez JF, Guedea F, et al; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiation Oncology Bio Phys. 2008;72(2):421-432.
27. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst. 2009;101(12):888-892.
28. Miller DC, Wei JT, Dunn RL, et al. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology. 2006;68(1):166-171.
29. Wilt TJ, Shamliyan TA, Taylor BC, MacDonald R, Kane RL. Association between hospital and surgeon radical prostatectomy volume and patient outcomes: A systematic review. J Urol. 2008;180(3):820-828; discussion 828-829.
30. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772-2780.
31. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin. 2008;58(4):196-213.
32. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92(19):1582-1592.
33. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst . 2004;96(18):1358-1367.
34. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20(2):557-566.
35. Harrington CB, Hansen JA, Moskowitz M, Todd BL, Fuerestein M. It’s not over when it’s over: Long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med. 2010;40(2):163-181.
36. Pardo Y, Guedea F, Aguiló F, et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment [published correction appears in J Clin Oncol . 2011;29(6):779]. J Clin Oncol. 2010;28(31):4687-4696.
37. Baumann FT, Zoph EM, Bloch W. Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials. Support Care Cancer. 2011;20(2):221-233.
38. Goode PS, Burgio KL, Johnson TM II, et al. Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: A randomized controlled trial. JAMA . 2011;305(2):151-159.
39. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726-732.
40. Meldrum DR, Gambone JC, Morris MA, Ignarro LJ. A multifaceted approach to maximize erectile function and vascular health. Fertil Steril. 2010;94(7):2514-2520.
41. National Cancer Institute. Gastrointestinal Complications. NCCN Website. http://www.cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional. Accessed June 27, 2014.
42. Michigan Cancer Consortium. Michigan Cancer Consortium Recommendations for Prostate Cancer Survivorship Care. Prostate Cancer Decision Website. http://www.prostatecancerdecision.org/PDFs/Algorithms2013/RecommProstateCancerCare-09182013.pdf. Accessed April 10, 2014.
43. Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, et al. Advancing survivorship care through the National Cancer Survivorship Resource Center: Developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin. 2013;63(3):147-150.
44. American Society of Clinical Oncology. Cancer Survivorship. American Society of Clinical Cancer Website. http://www.asco.org/practice-research
45. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Survivorship. V1. 2014. NCCN Website. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#survivorship. Accessed April 24, 2014.
46. Skolarus TA, Holmes-Rovner M, Northouse LL, et al. Primary care perspectives on prostate cancer survivorship: Implications for improving quality of care. Urol Oncol. 2013;31(6):727-732.
47. Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: Challenges to assuring access to oncology services. J Oncol Pract. 2007;3(2):79-86.
48. VHA Office of Productivity, Efficiency, & Staffing (OPES). Fiscal Year 2011 VHA Physician Workforce & Support Staff Data by VISN Facility. Washington, DC: VHA Office of Productivity, Efficiency, & Staffing; 2011.
49. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. Urologist density and county-level urologic cancer mortality. J Clin Oncol. 2010;28(15):2499-2504.
50. Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR. Geographic distribution of urologists throughout the United States using a county level approach. J Urol. 2009;181(2):760-765; discussion 765-766.
51. Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC. Care of long-term cancer survivors: Physicians seen by Medicare enrollees surviving longer than 5 years. Cancer. 2009;115(22):5284-5295.
52. Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: Implementing the survivorship care plan. Semin Oncology Nurs. 2008;24(3):208-217.
53. Bober SL, Recklitis CJ, Campbell EG, et al. Caring for cancer survivors: A survey of primary care physicians. Cancer. 2009;115(suppl 18):4409-4418.
54. Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27(15):2489-2495.
55. Skolarus TA, Zhang Y, Hollenbeck BK. Understanding fragmentation of prostate cancer survivorship care: Implications for cost and quality. Cancer. 2012;118(11):2837-2845.
56. Grimshaw JM, Winkens RA, Shirran L, et al. Interventions to improve outpatient referrals from primary care to secondary care. Cochrane Database Syst Rev. 2005;(3):CD005471.
57. Skolarus TA, Wolf AM, Erb NL, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin . 2014;64(4):225-249.
58. Jacobs LA, Palmer SC, Schwartz LA, et al. Adult cancer survivorship: Evolution, research, and planning care. CA Cancer J Clin. 2009;59(6):391-410.
59. O’Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: Finding common ground. Arch Intern Med . 2011;171(1):56-65.
60. Krein SL, Damschroder LJ, Kowalski CP, Forman J, Hofer TP, Saint S. The influence of organizational context on quality improvement and patient safety efforts in infection prevention: A multi-center qualitative study. Soc Sci Med . 2010;71(9):1692-1701.
61. McDermott KA, Helfrich CD, Sales AE, Rumsfeld JS, Ho PM, Fihn SD. A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction. J Gen Intern Med. 2008;23(8):1246-1256.
62. Grimshaw JM, Zwarenstein M, Tetroe JM, et al. Looking inside the black box: A theory-based process evaluation alongside a randomised controlled trial of printed educational materials (the Ontario printed educational message, OPEM) to improve referral and prescribing practices in primary care in Ontario, Canada. Implement Sci. 2007;2:38.
63. Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci . 2011;6:26.
64. Godin G, Bélanger-Gravel A, Eccles M, Grimshaw J. Healthcare professionals’ intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci. 2008;2008(3):36.
65. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii-iv, 1-72.
66. Hysong SJ, Teal CR, Khan MJ, Haidet P. Improving quality of care through improved audit and feedback. Implement Sci. 2012;7(1):45.
67. Hysong SJ. Meta-analysis: Audit and feedback features impact effectiveness on care quality. Med Care. 2009;47(3):356-363.
68. Hysong SJ, Best RG, Pugh JA. Audit and feedback and clinical practice guideline adherence: Making feedback actionable. Implement Sci . 2006;1:9.
69. Sales AE, Schalm C. Data for improvement and clinical excellence: Protocol for an audit with feedback intervention in long-term care. Implement Sci. 2010;5(1):74.
70. Helfrich CD, Blevins D, Smith JL, et al. Predicting implementation from organizational readiness for change: A study protocol. Implement Sci. 2011;6(1):76.
71. Pineros SL, Sales AE, Li YF, Sharp ND. Improving care to patients with ischemic heart disease: Experiences in a single network of the Veterans Health Administration. Worldviews Evid Based Nurs. 2004;1(suppl 1):S33-S40.
72. Sales AE, Pineros SL, Magid DJ, Every NR, Sharp ND, Rumsfeld JS. The association between clinical integration of care and transfer of veterans with acute coronary syndromes from primary care VHA hospitals. BMC Health Serv Res. 2005;5(1):2.
73. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012;7(1):50.
74. Sales AE, Lapham GG, Squires J, et al. Organizational factors associated with decreased mortality among Veterans Affairs patients with an ICU stay. Comput Inform Nurs. 2011;29(9):496-501.
75. Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25(2):194-205.
76. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.
77. Salkeld E, Leaver CA, Guttmann A, et al. Barriers and facilitators to the implementation of Ontario’s emergency department clinical decision unit pilot program: A qualitative study. CJEM. 2011;13(6):363-371.
78. Sharp ND, Pineros SL, Hsu C, Starks H, Sales AE. A qualitative study to identify barriers and facilitators to implementation of pilot interventions in the Veterans Health Administration (VHA) Northwest Network. Worldviews Evid Based Nurs. 2004;1(2):129-139.
79. Render ML, Hasselbeck R, Freyberg RW, Hofer TP, Sales AE, Almenoff PL; VA ICU Clinical Advisory Group. Reduction of central line infections in Veterans Administration intensive care units: An observational cohort using a central infrastructure to support learning and improvement. BMJ Qual Saf. 2011;20(8):725-732.
80. Grimshaw JM, Eccles MP, Steen N, et al. Applying psychological theories to evidence-based clinical practice: Identifying factors predictive of lumbar spine x-ray for low back pain in UK primary care practice. Implement Sci. 2011;6(1):55.
81. Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N. Changing the behavior of healthcare professionals: The use of theory in promoting the uptake of research findings. J Clin Epidemiol . 2005;58(2):107-112.
82. Davies P, Walker AE, Grimshaw JM. A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implement Sci . 2010;5(1):14.
83. Sales A, Smith J, Curran G, Kochevar L. Models, strategies, and tools. Theory in implementing evidence-based findings into health care practice. J Gen Intern Med. 2006;21(suppl 2):S43-S49.
84. Dixon-Woods M, Bosk CL, Aveling EL, Goeschel CA, Pronovost PJ. Explaining Michigan: Developing an ex post theory of a quality improvement program. Milbank Q . 2011;89(2):167-205.
85. Damschroder LJ, Goodrich DE, Robinson CH, Fletcher CE, Lowery JC. A systematic exploration of differences in contextual factors related to implementing the MOVE! weight management program in VA: A mixed methods study. BMC Health Serv Res. 2011;11(1):248.
86. Ramsay CR, Thomas RE, Croal BL, Grimshaw JM, Eccles MP. Using the theory of planned behaviour as a process evaluation tool in randomised trials of knowledge translation strategies: A case study from UK primary care. Implement Sci. 2010;5(1):71.
87. Légaré F, Borduas F, Jacques A, et al. Developing a theory-based instrument to assess the impact of continuing professional development activities on clinical practice: A study protocol. Implement Sci. 2011;6(1):17.
88. French SD, Green SE, O’Connor DA, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: A systematic approach using the Theoretical Domains Framework. Implement Sci. 2012;7(1):38.
89. Ajzen I. The theory of planned behaviour: Reactions and reflections. Psychol Health. 2011;26(9):1113-1127.
90. Fishbein M, Ajzen I. Theory-based behavior change interventions: Comments on Hobbis and Sutton. J Health Psychol. 2005;10(1):27-31; discussion 37-43.
91. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
92. Francis JJ, O’Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: Introducing a thematic series on the theoretical domains framework. Implement Sci. 2012;7(1):35.
93. Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care. Hepatology. 2010;52(3):1124-1133.
94. Arora S, Kalishman S, Dion D, et al. Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care. Health Aff (Milwood) . 2011;30(6):1176-1184.
95. Horner K, Wagner E, Tufano J. Electronic consultations between primary and specialty care clinicians: Early insights. Issue Brief (Commonw Fund). 2011;23:1-14.
96. Kunitake H, Zheng P, Yothers G, et al. Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01. J Clin Oncol. 2010;28(36):5274-5279.
97. Ng A, Constine LS, Advani R; Expert Panel on Radiation Oncology-Hodgkin’s Lymphoma. ACR Appropriateness Criteria follow-up of Hodgkin’s lymphoma. [online publication]. Reston (VA): American College of Radiology (ACR); 2010.
